Optimized preoperative determination of nerve of origin in patients with vestibular schwannoma.
Adolescent
Adult
Aged
Audiometry, Pure-Tone
/ methods
Double-Blind Method
Female
Head Impulse Test
/ methods
Hearing
/ physiology
Humans
Male
Middle Aged
Neurilemmoma
/ pathology
Neuroma, Acoustic
/ pathology
Prospective Studies
Semicircular Canals
/ pathology
Vestibular Evoked Myogenic Potentials
/ physiology
Vestibular Nerve
/ pathology
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 04 2021
21 04 2021
Historique:
received:
01
02
2021
accepted:
30
03
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
11
11
2021
Statut:
epublish
Résumé
In vestibular schwannoma (VS) patients hearing outcome and surgery related risks can vary and depend on the nerve of origin. Preoperative origin differentiation between inferior or superior vestibular nerve may influence the decision on treatment, and the selection of optimal treatment and counselling modalities. A novel scoring system based on functional tests was designed to predict the nerve of origin for VS and was applied to a large number of consecutive patients. A prospective, double blind, cohort study including 93 patients with suspected unilateral VS was conducted at a tertiary referral centre. Preoperatively before tumor resection a functional test battery [video head-impulse test (vHIT) of all semicircular canals (SCC)], air-conducted cervical/ocular vestibular evoked myogenic potential tests (cVEMP, oVEMP), pure-tone audiometry, and speech discrimination was applied. Sensitivity and specificity of prediction of intraoperative finding by a preoperative score based on vHIT gain, cVEMP and oVEMP amplitudes and asymmetry ratios was calculated. For the prediction of inferior vestibular nerve origin, sensitivity was 73% and specificity was 80%. For the prediction of superior vestibular nerve origin, sensitivity was 60% and specificity was 90%. Based on the trade-off between sensitivity and specificity, optimized cut-off values of - 0.32 for cVEMP and - 0.11 for oVEMP asymmetry ratios and vHIT gain thresholds of 0.77 (anterior SCC), 0.84 (lateral SCC) and 0.80 (posterior SCC) were identified by receiver operator characteristic curves. The scoring system based on preoperative functional tests improves prediction of nerve of origin and can be applied in clinical routine.
Identifiants
pubmed: 33883565
doi: 10.1038/s41598-021-87515-1
pii: 10.1038/s41598-021-87515-1
pmc: PMC8060325
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8608Références
Neuro Oncol. 2016 Nov;18(11):1498-1507
pubmed: 27194145
Otol Neurotol. 2010 Jan;31(1):147-52
pubmed: 19816224
Front Neurol. 2015 Jul 08;6:154
pubmed: 26217301
Otol Neurotol. 2015 Sep;36(9):1547-53
pubmed: 26375978
J Vestib Res. 2014;24(5-6):365-73
pubmed: 25564079
J Neurosurg. 2011 Nov;115(5):900-5
pubmed: 21800963
Adv Clin Exp Med. 2018 Mar;27(3):335-341
pubmed: 29533538
Auris Nasus Larynx. 2001 Jan;28(1):41-3
pubmed: 11137362
Clin Otolaryngol. 2016 Oct;41(5):532-8
pubmed: 26453356
Ann Otol Rhinol Laryngol. 1988 Jan-Feb;97(1):55-66
pubmed: 3277525
Oper Neurosurg (Hagerstown). 2019 Mar 1;16(3):319-325
pubmed: 29750273
PLoS One. 2014 Aug 19;9(8):e105026
pubmed: 25137289
Audiol Neurootol. 2007;12(1):1-12
pubmed: 17033159
Braz J Otorhinolaryngol. 2017 May - Jun;83(3):324-329
pubmed: 27174775
Otol Neurotol. 2015 Apr;36(4):647-52
pubmed: 25415462
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Am J Otol. 2000 May;21(3):417-24
pubmed: 10821558
Neurology. 2005 May 24;64(10):1682-8
pubmed: 15911791
Biochim Biophys Acta. 1975 Oct 20;405(2):442-51
pubmed: 1180967
Laryngoscope. 2007 Dec;117(12):2087-92
pubmed: 17921903
Otol Neurotol. 2008 Oct;29(7):1029-33
pubmed: 18698272
Am J Otol. 2000 Sep;21(5):712-5
pubmed: 10993464
Acta Otolaryngol. 2003 May;123(4):499-505
pubmed: 12797585
Otol Neurotol. 2020 Jun;41(5):e623-e629
pubmed: 32118807
HNO. 2018 Jan;66(Suppl 1):16-21
pubmed: 29079887
Laryngoscope. 2015 Dec;125(12):2784-9
pubmed: 26086320
Neuro Oncol. 2020 Jan 11;22(1):31-45
pubmed: 31504802
Audiol Neurootol. 2012;17(2):121-5
pubmed: 21968195
Chin Med J (Engl). 2016 Apr 5;129(7):799-803
pubmed: 26996474
J Neurosurg. 2006 Oct;105(4):527-35
pubmed: 17044553
Otolaryngol Head Neck Surg. 1995 Sep;113(3):179-80
pubmed: 7675475
Audiol Neurootol. 2014;19(5):327-35
pubmed: 25358828
Int J Audiol. 2013 Oct;52(10):713-8
pubmed: 23902522
Ann N Y Acad Sci. 2009 May;1164:486-91
pubmed: 19645955
PLoS One. 2013 Apr 22;8(4):e61488
pubmed: 23630593
Laryngoscope. 2002 Feb;112(2):267-71
pubmed: 11889382
Biomed Res Int. 2016;2016:4980562
pubmed: 27747231
HNO. 2021 Sep;69(9):750-758
pubmed: 32975608
Neurosurgery. 2015 Aug;77(2):218-27; discussion 227
pubmed: 25850598
Ann N Y Acad Sci. 1999 May 28;871:195-204
pubmed: 10372072
Sci Rep. 2015 Dec 22;5:18599
pubmed: 26690506
J Neurosurg. 1998 Mar;88(3):506-12
pubmed: 9488305
Otol Neurotol. 2020 Jun;41(5):694-703
pubmed: 31985710
Laryngoscope. 2002 Sep;112(9):1623-6
pubmed: 12352676
Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2143-8
pubmed: 24789061
Otol Neurotol. 2003 Jan;24(1):1
pubmed: 12544018
Eur Arch Otorhinolaryngol. 2013 Feb;270(2):497-504
pubmed: 22526579
Clin Neurophysiol Pract. 2019 Feb 26;4:47-68
pubmed: 30949613
J Laryngol Otol. 2008 Feb;122(2):128-31
pubmed: 18039415